The Washingtonian article is very sad, but I'm not sure I buy Tabarrok's take on it. He once again harps on GMP regulations, but doesn't Europe have similar regulations? And the very first page of the Washingtonian article mentions a case where 9 patients died because a substitute PN was contaminated - to what extent would reducing oversight lead to even more such incidents? I'm open to the idea that FDA regulations are an issue but it hardly seems like that's the most pressing problem, given all of the other issues with our healthcare system.